Clinical Trials on Postoperative Thromboembolism

Total 9949 results

Jewish General Hospital

Recruiting

Assessment of Recovery of Functional Capillary Surface Area in Patients Undergoing a Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension

Hypertension, Pulmonary | Pulmonary Thromboembolisms

Canada
Rigshospitalet, Denmark

Completed

Frequency of Vascular Events With Short-term Thromboprophylaxis in Fast-track Hip and Knee-arthroplasty. (FETA)

Thromboembolic Events | Post-operative Bleeding

Denmark
University Hospital, Brest

Unknown

Risk Factors of Venous Thromboembolism in Women During Hormonal Exposure (FIT-H)

Venous Thromboembolic Disease

France
CHU de Reims

Completed

Elaboration of a Prioritization Score for Pharmaceutical Interviews in Patients Treated With Oral Anticoagulants

Thromboembolic Event

France
Emory University
National Association of Orthopaedic Nurses

Completed

App Reminder on ASA Adherence

Thromboembolic Event

United States
University Hospital, Geneva

Completed

Pharmacogenetics of Acenocoumarol

Thromboembolic Diseases

Switzerland
Direction Centrale du Service de Santé des Armées

Recruiting

Comparison of the 'CTR' Ratio With Standard Haemostasis Parameters in the Follow-up of Patients Undergoing Heparin Therapy (QuantiXa)

Venous Thromboembolic Disease

France
Qianfoshan Hospital

Not yet recruiting

Value of D-dimer Combined With Other Thrombus Molecular Markers in Risk Assessment of VTE in Hospitalized Patients

Venous Thromboembolic Disease

China
ThromboGenics
BioInvent International AB

Completed

Single IV Administration of TB-402 for Prophylaxis of Venous Thromboembolic Events (VTE) After Total Hip Replacement Surgery

Prophylaxis of Venous Thromboembolic Events

Austria, Netherlands, Belgium, Bulgaria, Hungary, Latvia, Poland, Russian Federation, Ukraine
Centre Hospitalier Universitaire de Saint Etienne

Completed

Predictors of Attempted Inferior Vena Cava Filters Retrieval.

Venous Thromboembolic Disease

France
University Hospital, Strasbourg, France

Recruiting

Comparative Study of the Hemorrhagic Risk in Patients Over 75 Years of Age Taking Enoxaparin (ENOX-VTD-H)

Venous Thromboembolic Disease

France
Centre Hospitalier Eure-Seine

Not yet recruiting

Impact of Remote Care in Patients Diagnosed With Thromboembolic Disease of Low Risk (TEVEDOM)

Thromboembolic Disease
DSM Nutritional Products, Inc.

Completed

Clinical Performance Evaluation of Pefakit® PiCT® UC In Vitro Diagnostic Medical Device

Thromboembolic Events

Germany, United States, Switzerland
Klein, Jeffrey A., M.D.

Completed

Effect of Tumescent Lidocaine on Platelet Function

Postoperative Thromboembolism

United States
University Hospital, Strasbourg, France

Unknown

Cost Effectiveness Analysis of an Ancillary Study of the REMOTEV Study

Venous Thromboembolic Disease

France
University Hospital, Strasbourg, France

Unknown

Observational Prospectif Monocentric Registry of Patients Suffering From VIE (REMOTEV)

Venous Thromboembolic Disease

France
Delos Clinical

Completed

Time of Treatment With LMWH in Cancer Patients With Thromboembolic Disease

Cancer | Venous Thromboembolism | Pulmonary Thromboembolisms
Navy General Hospital, Beijing

Not yet recruiting

Smart Technology Facilitated Patient-centered Care for Patients With Pulmonary Thromboembolism (SmaPE)

Venous Thromboembolism | Clinical Decision Support Systems | Digital Health | Pulmonary Thromboembolisms

China
University of Pennsylvania
OsciFlex LLC

Completed

OsciPulse Device for the Prevention of VTE

Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Thromboembolisms

United States
Odense University Hospital

Completed

The Role of FDG-PET/CT Imaging in the Management of Patients With Thromboembolic Disorders (The PETVET Study) (PETVET)

Venous Thromboembolic Disease

Denmark
Central Hospital, Nancy, France

Completed

Safety of Direct Oral Anticoagulant During Pregnancy (SACOD)

Thromboembolic Disease

France
Centre Hospitalier Sud Francilien

Completed

Thromboprophylaxis by Low Molecular Heparin During the Post-partum Period (THROM-PP2021)

Thromboembolic Disease

France
Bayer
Janssen Research & Development, LLC

Completed

A Trial to Learn How a New Liquid Form of Rivaroxaban Behaves and How Safe it is Compared to the Current Tablet Form of Rivaroxaban in Healthy Male Participants

Thromboembolic Disorders

Germany
Second Affiliated Hospital of Wenzhou Medical University

Unknown

An Analysis Into the Cause and Preventional Method of Thromboembolic Disease in Gynecological Surgery

Thromboembolic Disease | Gynecological Surgery

China
Thomas Guerrero

Completed

Non-Contrast 4DCT to Detect Pulmonary Thromboembolic Events

Pulmonary Embolism | Pulmonary Thromboembolisms

United States
Amsterdam UMC, location VUmc
Trombosestichting Nederland

Recruiting

BPA in CTEPD Without PH (BALLOON)

Chronic Thromboembolic Disease

Netherlands
University of Colorado, Denver
Bayer

Recruiting

Treatment of Exercise-Induced Pulmonary Vascular Dysfunction After Pulmonary Thromboendarterectomy or Balloon Pulmonary Angioplasty

Chronic Thromboembolic Disease (CTED) | Exercise Intolerance Post PEA Surgery

United States
Hawler Medical University

Completed

Comparison of 2 Low Molecular Weight Heparin as a Thromboprophylaxis Postpartum

Venous Thromboembolic Diseases

Iraq
Institut de Cancérologie de la Loire
Centre Hospitalier Universitaire de Saint Etienne; CH Roanne

Completed

Radiation Impact on Thromboembolic Events (RIT)

Malignant Neoplasm

France
AstraZeneca

Terminated

Melagatran/Ximelagatran Versus Enoxaparin for the Prevention of Venous Thromboembolic Events (EXTEND)

Thromboembolism

Sweden, France, Mexico, Poland, South Africa, Spain, Germany, Hungary, Denmark, Finland, Netherlands, Norway, Austria, Belgium, Portugal, Switzerland
GlaxoSmithKline

Completed

CV Events in Emetogenic Chemotherapy

Vomiting | Cardiovascular Event | Arterial Thromboembolic Event
Institut Cancerologie de l'Ouest
Diagnostica Stago

Recruiting

Thrombin Generation and Prediction of Thromboembolic Events in Oncology Patients at Risk (THROMBIN)

Solid Carcinoma

France
TeaRx LLC

Completed

Safety and Efficacy of TeaRx Xa Factor Direct Inhibitor Versus Enoxaparin as a Venous Thromboembolic Events (VTE) Prevention Following Total Knee Replacement

Total Knee Replacement

Russian Federation
Les Laboratoires des Médicaments Stériles

Completed

Comparison of Thromboembolic Events in Patients Undergoing Thromboprophylactic Treatment With ENOXA® vs Lovenox® (ENOXACARE)

Gastrointestinal Neoplasms | Thromboembolic Event

Tunisia
Centre Hospitalier Universitaire de Saint Etienne
Ministry of Health, France

Recruiting

Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets (BAT-VTE)

Venous Thromboembolic Disease

France
Sanofi

Completed

Enoxaparin in Acute Venous Thromboembolic Disease

Venous Thrombosis

Turkey
Sociedad Española de Neumología y Cirugía Torácica

Completed

Longitudinal Study to Identify Predictive Factors of Post-thrombotic Pulmonary Hypertension

Pulmonary Hypertension | Pulmonary Thromboembolisms

Spain
Duke University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Effectiveness of Bridging Anticoagulation for Surgery (The BRIDGE Study)

Atrial Fibrillation | Arterial Thromboembolic Events

United States
ThromboGenics
Covance; BioInvent International AB

Completed

Single Intravenous Administration of TB-402 for the Prophylaxis of Venous Thromboembolic Events (VTE) After Total Knee Replacement Surgery

Total Knee Replacement Surgery

Israel, Romania, Bulgaria, Latvia, Poland, Russian Federation, Ukraine
Ottawa Hospital Research Institute

Completed

Clinical Predictors for Venous Thromboembolism in Patients With a History of Thrombosis (PREDICTORS) (PREDICTORS)

Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism | Thromboembolic Disease Recurrent | Recurrent Thromboembolic Disease

Canada, Netherlands, Switzerland
C. R. Bard

Completed

Prospective, Multi-center, Single-arm Study to Assess the Safety of Retrieval of the Recovery G2 Filter. (EVEREST)

Pulmonary Embolism | Venous Thromboembolic Disease
Bayer

Completed

An Observational Study (Called RETAF-PS) Using a Patient Survey to Learn More About Treatment Outcomes in Patients With Irregular and Often Rapid Heartbeat (Atrial Fibrillation) Treated With Apixaban in a Real World Setting

Atrial Fibrillation | Prevention of Thromboembolic Events

United States
University of California, San Francisco

Recruiting

Chronic Thromboembolic Disease Registry

Chronic Thromboembolic Pulmonary Hypertension | Chronic Thromboembolic Disease

United States
Montefiore Medical Center
The Plastic Surgery Foundation

Completed

Use of Tranexamic Acid in Reduction Mammoplasty (TREX-ARM)

Venous Thromboembolism | Hematoma Postoperative

United States
Xiangya Hospital of Central South University

Recruiting

Personalized Anticoagulant Therapy for Pulmonary Thromboembolism

Pulmonary Thromboembolisms | Anticoagulants; Increased

China
Floralis
University Hospital, Grenoble

Completed

Evaluation of the Prevention of Thromboembolic Disease in Patients With a Lower Limb Trauma, Non Surgical, in Winter Sports Resort (M2M-Thrombose)

Leg Injuries | Outpatients | Winter Sport Resorts

France
China-Japan Friendship Hospital

Recruiting

CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism

Venous Thromboembolism | Pulmonary Embolism | Deep Venous Thrombosis | Quality Improvement | Venous Thromboembolic Disease

China
Hvidovre University Hospital

Completed

Evaluation of Intraarticular Tranexamic Acid to Reduction of Total Blood Loss Following Knee-Arthroplasty

Blood Loss | Postoperative Blood Loss | Thromboembolic Complications

Denmark
University of Sheffield
Sheffield Teaching Hospitals NHS Foundation Trust

Unknown

Iodine Subtraction Mapping in the Diagnosis of Chronic Pulmonary Thromboembolic Disease (INSPIRE)

Chronic Thromboembolic Pulmonary Hypertension
CSL Behring
Kaiser Permanente

Completed

An Observational Cohort Study to Investigate the Risk of Thromboembolic Events in Patients Receiving Kcentra® or Plasma to Reverse Vitamin K Antagonist (VKA) Therapy in the Setting of Acute Major Bleeding

Hemorrhage

United States

Clinical Trials on Postoperative Thromboembolism

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uzbekistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations